Prana Thoracic Completes Series A Extension of 3 Million in Oversubscribed Round, Bringing Total Funding to 9 Million
ATHE Stock | USD 3.34 0.38 10.22% |
About 61% of Alterity Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Alterity Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Alterity Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Alterity Therapeutics stock news signals to limit their universe of possible portfolio assets.
Alterity |
HOUSTON, August 07, 2024--Prana Thoracic, a Houston-based medtech startup, founded with a vision to transform lung cancer intervention, proudly announces the successful final closing of its Series A extension round. The company initially raised 3M, received a non-dilutive grant of 3M, and has now closed on an additional 3M in oversubscribed funding. This marks a significant milestone in its journey to advance precision surgical solutions.
Read at finance.yahoo.com
Alterity Therapeutics Fundamental Analysis
We analyze Alterity Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterity Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterity Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Alterity Therapeutics is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Alterity Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alterity Therapeutics stock to make a market-neutral strategy. Peer analysis of Alterity Therapeutics could also be used in its relative valuation, which is a method of valuing Alterity Therapeutics by comparing valuation metrics with similar companies.
Peers
Alterity Therapeutics Related Equities
ARTL | Artelo Biosciences | 1.74 | ||||
ANEB | Anebulo Pharmaceuticals | 0.61 | ||||
SRZN | Surrozen | 1.08 | ||||
TARA | Protara Therapeutics | 1.17 | ||||
PMVP | Pmv Pharmaceuticals | 1.95 | ||||
HCWB | HCW Biologics | 2.44 | ||||
MNPR | Monopar Therapeutics | 2.78 | ||||
NBY | NovaBay Pharmaceuticals | 3.03 | ||||
ANTX | AN2 Therapeutics | 3.70 | ||||
ATXI | Avenue Therapeutics | 4.62 | ||||
ADIL | Adial Pharmaceuticals | 4.67 | ||||
RNAZ | Transcode Therapeutics | 4.99 | ||||
QNRX | Quoin Pharmaceuticals | 6.06 | ||||
RVPH | Reviva Pharmaceuticals | 6.50 | ||||
ADTX | Aditxt | 10.53 |
Complementary Tools for Alterity Stock analysis
When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |